Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications
Top Cited Papers
Open Access
- 25 July 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 17 (6), 772-790
- https://doi.org/10.1093/humupd/dmr031
Abstract
Growth factors are proteins secreted by a number of cell types that are capable of modulating cellular growth, proliferation and cellular differentiation. It is well accepted that uterine cellular events such as proliferation and differentiation are regulated by sex steroids and their actions in target tissues are mediated by local production of growth factors acting through paracrine and/or autocrine mechanisms. Myometrial mass is ultimately modified in pregnancy as well as in tumour conditions such as leiomyoma and leiomyosarcoma. Leiomyomas, also known as fibroids, are benign tumours of the uterus, considered to be one of the most frequent causes of infertility in reproductive years in women. For this review, we searched the database MEDLINE and Google Scholar for articles with content related to growth factors acting on myometrium; the findings are hereby reviewed and discussed. Different growth factors such as epidermal growth factor (EGF), transforming growth factor-α (TGF-α), heparin-binding EGF (HB-EGF), acidic fibroblast growth factor (aFGF), basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), platelet-derived growth factor (PDGF) and TGF-β perform actions in myometrium and in leiomyomas. In addition to these growth factors, activin and myostatin have been recently identified in myometrium and leiomyoma. Growth factors play an important role in the mechanisms involved in myometrial patho-physiology.Keywords
This publication has 155 references indexed in Scilit:
- Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometriumThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Transforming growth interacting factor expression in leiomyoma compared with myometriumFertility and Sterility, 2010
- The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cellsFertility and Sterility, 2010
- Receptor Tyrosine Kinases and Their Hormonal Regulation in Uterine LeiomyomaSeminars in Reproductive Medicine, 2010
- Proinflammatory and Profibrotic Mediators: Principal Effectors of Leiomyoma Development as a Fibrotic DisorderSeminars in Reproductive Medicine, 2010
- Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristoneInternational Journal of Gynecology & Obstetrics, 2010
- Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labourEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2009
- Estrogen receptor alpha (ERα) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometriumVirchows Archiv A Pathological Anatomy and Histopathology, 2008
- Current development of mTOR inhibitors as anticancer agentsNature Reviews Drug Discovery, 2006
- A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattleNature Genetics, 1997